X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (25653) 25653
Publication (1866) 1866
Newspaper Article (912) 912
Newsletter (536) 536
Book Review (464) 464
Book Chapter (188) 188
Magazine Article (98) 98
Trade Publication Article (62) 62
Transcript (43) 43
Book / eBook (28) 28
Conference Proceeding (28) 28
Dissertation (19) 19
Web Resource (10) 10
Reference (5) 5
Government Document (4) 4
Paper (3) 3
Report (3) 3
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18167) 18167
anticoagulants (13469) 13469
index medicus (11744) 11744
male (8837) 8837
female (8624) 8624
anticoagulants - therapeutic use (6747) 6747
middle aged (5611) 5611
aged (5102) 5102
hematology (4487) 4487
adult (4327) 4327
animals (4309) 4309
anticoagulants - administration & dosage (4194) 4194
warfarin (3732) 3732
thrombosis (3672) 3672
peripheral vascular disease (3465) 3465
anticoagulants - adverse effects (3342) 3342
risk factors (3264) 3264
dose-response relationship, drug (3227) 3227
heparin (3167) 3167
anticoagulants - pharmacology (2916) 2916
cardiac & cardiovascular systems (2740) 2740
treatment outcome (2617) 2617
analysis (2596) 2596
pharmacology & pharmacy (2563) 2563
thromboembolism (2443) 2443
surgery (2268) 2268
stroke (2140) 2140
aged, 80 and over (2017) 2017
anticoagulation (1991) 1991
care and treatment (1974) 1974
prevention (1941) 1941
research (1895) 1895
glycosaminoglycans (1861) 1861
atrial fibrillation (1857) 1857
venous thromboembolism (1853) 1853
thrombin (1840) 1840
health aspects (1839) 1839
therapy (1825) 1825
drug therapy (1812) 1812
medicine & public health (1737) 1737
patients (1709) 1709
blood coagulation - drug effects (1633) 1633
anticoagulant (1622) 1622
administration, oral (1566) 1566
coagulation (1566) 1566
risk (1554) 1554
time factors (1542) 1542
mortality (1523) 1523
warfarin - therapeutic use (1509) 1509
medicine, general & internal (1501) 1501
molecular-weight heparin (1491) 1491
retrospective studies (1462) 1462
management (1456) 1456
warfarin - administration & dosage (1418) 1418
heparin - therapeutic use (1377) 1377
international normalized ratio (1353) 1353
hemorrhage - chemically induced (1332) 1332
blood (1303) 1303
cardiology (1270) 1270
abridged index medicus (1255) 1255
prospective studies (1238) 1238
proteins (1194) 1194
adolescent (1190) 1190
venous thrombosis (1143) 1143
dosage and administration (1135) 1135
medicine (1111) 1111
mice (1106) 1106
atrial fibrillation - drug therapy (1099) 1099
rats (1092) 1092
aspirin (1055) 1055
medical research (1055) 1055
heparin - administration & dosage (1045) 1045
dabigatran (1034) 1034
deep-vein thrombosis (1034) 1034
rivaroxaban (1032) 1032
heparin - adverse effects (1029) 1029
heparin - pharmacology (1027) 1027
pregnancy (1016) 1016
studies (1010) 1010
warfarin - adverse effects (980) 980
atrial-fibrillation (973) 973
internal medicine (972) 972
diagnosis (952) 952
inflammation (937) 937
usage (926) 926
cardiac arrhythmia (925) 925
follow-up studies (924) 924
biochemistry & molecular biology (916) 916
unfractionated heparin (912) 912
hemorrhage (907) 907
risk assessment (904) 904
plasma (902) 902
anticoagulants - pharmacokinetics (895) 895
clinical trials (876) 876
bleeding (875) 875
disease (867) 867
platelet aggregation inhibitors - therapeutic use (865) 865
partial thromboplastin time (861) 861
article (856) 856
stroke - prevention & control (841) 841
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (26870) 26870
French (200) 200
German (178) 178
Japanese (92) 92
Spanish (77) 77
Russian (72) 72
Chinese (24) 24
Portuguese (21) 21
Italian (14) 14
Dutch (12) 12
Hungarian (8) 8
Korean (6) 6
Polish (5) 5
Turkish (4) 4
Danish (3) 3
Hebrew (3) 3
Norwegian (3) 3
Czech (2) 2
Romanian (2) 2
Serbian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Finnish (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2010, Volume 55, Issue 3, pp. 213 - 220
Journal Article
Journal Article
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 08/2014, Volume 98, Issue 8, p. 1136
  [...]we would agree that continuation of antiplatelet and/or anticoagulant medications in the vast majority of patients undergoing cataract surgery is the... 
Cataracts | Anticoagulants | Surgery | Eye surgery
Journal Article
Journal Article
Journal of intensive care medicine, 02/2018, Volume 33, Issue 2, p. 143
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 05/2012, Volume 107, Issue 5, pp. 925 - 934
Edoxaban is a novel, orally available, highly specific direct inhibitor of factor Xa and is currently being developed for the treatment and prevention of... 
Atrial fibrillation | edoxaban | Factor Xa inhibitor | population pharmacokinetics | Blood Coagulation, Fibrinolysis and Cellular Haemostasis | Edoxaban | Population phar-macokinetics | SAFETY | PREVENTION | PHARMACODYNAMICS | ANTICOAGULATION | TRIAL | atrial fibrillation | VENOUS THROMBOEMBOLISM | PHARMACOKINETICS | DRUG DEVELOPMENT | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | factor Xa inhibitor | HEMATOLOGY | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Male | Thiazoles - therapeutic use | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Clinical Trials, Phase III as Topic - methods | Dose-Response Relationship, Drug | Drug Interactions | Computer Simulation | Female | Kidney Diseases - complications | Pyridines - therapeutic use | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | Logistic Models | Treatment Outcome | Stroke - drug therapy | Models, Statistical | Anticoagulants - adverse effects | Factor Xa - metabolism | Atrial Fibrillation - blood | Stroke - blood | Stroke - etiology | Blood Coagulation - drug effects | Models, Biological | Anticoagulants - pharmacokinetics | Hemorrhage - chemically induced | Research Design
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 09/2010, Volume 104, Issue 3, pp. 642 - 649
Edoxaban is a new oral direct factor Xa inhibitor. The purpose of this study was to evaluate the efficacy and safety of different doses of edoxaban for the... 
Thromboprophylaxis | Edoxaban | Anticoagulant therapy | Venous thromboembolism | Factor Xa inhibitor | Dalteparin - administration & dosage | Pulmonary Embolism - prevention & control | Anticoagulants - administration & dosage | Factor Xa Inhibitors | United States | Humans | Middle Aged | Venous Thrombosis - blood | Venous Thrombosis - diagnostic imaging | Male | Thiazoles - administration & dosage | Thiazoles - adverse effects | Venous Thromboembolism - blood | Fibrinolytic Agents - adverse effects | Venous Thromboembolism - prevention & control | Pyridines - adverse effects | Time Factors | Injections, Subcutaneous | Female | Venous Thrombosis - prevention & control | Venous Thromboembolism - diagnostic imaging | Pulmonary Embolism - diagnostic imaging | Pyridines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Administration, Oral | Europe | Risk Factors | Dalteparin - adverse effects | Logistic Models | Treatment Outcome | Anticoagulants - adverse effects | Arthroplasty, Replacement, Hip - adverse effects | Factor Xa - metabolism | Venous Thrombosis - etiology | Phlebography | Pulmonary Embolism - blood | Venous Thromboembolism - etiology | Canada | Pulmonary Embolism - etiology | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Elective Surgical Procedures | Surgery | venous thromboembolism | thromboprophylaxis | Kirurgi | edoxaban | anticoagulant therapy
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 03/2015, Volume 55, Issue 3, pp. 258 - 260
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 11/2014, Volume 70, Issue 11, pp. 1339 - 1351
Journal Article
Journal Article
Journal Article